Literature DB >> 25099263

Vancomycin-bearing synthetic bone graft delivers rhBMP-2 and promotes healing of critical rat femoral segmental defects.

Jordan D Skelly1, Jeffrey Lange, Tera M Filion, Xinning Li, David C Ayers, Jie Song.   

Abstract

BACKGROUND: Bone grafts simultaneously delivering therapeutic proteins and antibiotics may be valuable in orthopaedic trauma care. Previously, we developed a poly(2-hydroxyethyl methacrylate)-nanocrystalline hydroxyapatite (pHEMA-nHA) synthetic bone graft that, when preabsorbed with 400-ng rhBMP-2/7, facilitated the functional repair of critical-size rat femoral defects. Recently, we showed that pHEMA-nHA effectively retains/releases vancomycin and rhBMP-2 in vitro. The success of such a strategy requires that the incorporation of vancomycin does not compromise the structural integrity of the graft nor its ability to promote bone healing. QUESTIONS/PURPOSES: (1) To evaluate the ability of pHEMA-nHA-vancomycin composites in combination with 3-µg rhBMP-2 to repair 5 mm rat femoral segmental defects, and (2) To determine if the encapsulated vancomycin impairs the graft/rhBMP-2-assisted bone repair.
METHODS: pHEMA-nHA-vancomycin, pHEMA-nHA, or collagen sponge control with/without 3-µg rhBMP-2 were press-fit in 5 mm femoral defects in SASCO-SD male rats (289-300 g). Histology, microcomputed tomography, and torsion testing were performed on 8- and 12-week explants to evaluate the extent and quality of repair. The effect of vancomycin on the temporal absorption of endogenous BMP-2 and stromal cell-derived factor-1 was evaluated by immunohistochemistry. These factors are important for bone healing initiation and stem cell recruitment, respectively.
RESULTS: Partial bridging of the defect with bony callus by 12 weeks was observed with pHEMA-nHA-vancomycin without rhBMP-2 while full bridging with substantially mineralized callus and partial restoration of torsional strength was achieved with 3-µg rhBMP-2. The presence of vancomycin changed the absorption patterns of endogenous proteins on the grafts, but did not appear to substantially compromise graft healing.
CONCLUSIONS: The composite pHEMA-nHA-vancomycin preabsorbed with 3-µg rhBMP-2 promoted repair of 5 mm rat femoral segmental defects. With the sample sizes applied, vancomycin encapsulation did not appear to have a negative effect on bone healing. CLINICAL RELEVANCE: pHEMA-nHA-vancomycin preabsorbed with rhBMP-2 may be useful in the repair of critical-size long bone defects prone to infections.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25099263      PMCID: PMC4397773          DOI: 10.1007/s11999-014-3841-1

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  30 in total

Review 1.  Clinical applications of recombinant human BMPs: early experience and future development.

Authors:  Thomas A Einhorn
Journal:  J Bone Joint Surg Am       Date:  2003       Impact factor: 5.284

Review 2.  Bone allografts: What they can offer and what they cannot.

Authors:  C Delloye; O Cornu; V Druez; O Barbier
Journal:  J Bone Joint Surg Br       Date:  2007-05

Review 3.  Antibiotic-eluting medical devices for various applications.

Authors:  Meital Zilberman; Jonathan J Elsner
Journal:  J Control Release       Date:  2008-08-06       Impact factor: 9.776

Review 4.  Prophylactic antibiotics in orthopaedic surgery.

Authors:  Laura Prokuski
Journal:  J Am Acad Orthop Surg       Date:  2008-05       Impact factor: 3.020

Review 5.  Bone morphogenetic proteins for spinal fusion.

Authors:  Elliot Carlisle; Jeffrey S Fischgrund
Journal:  Spine J       Date:  2005 Nov-Dec       Impact factor: 4.166

6.  Iliac crest bone graft donor site pain after anterior lumbar interbody fusion: a prospective patient satisfaction outcome assessment.

Authors:  Rick C Sasso; Jean Charles LeHuec; Christopher Shaffrey
Journal:  J Spinal Disord Tech       Date:  2005-02

7.  Antibiotics for local delivery systems cause skeletal cell toxicity in vitro.

Authors:  Valentin Antoci; Christopher S Adams; Noreen J Hickok; Irving M Shapiro; Javad Parvizi
Journal:  Clin Orthop Relat Res       Date:  2007-09       Impact factor: 4.176

Review 8.  Bone morphogenetic proteins in clinical applications.

Authors:  Oliver P Gautschi; Sönke P Frey; René Zellweger
Journal:  ANZ J Surg       Date:  2007-08       Impact factor: 1.872

9.  Bone grafts as vancomycin carriers in local therapy of resistant infections.

Authors:  P Melicherčík; D Jahoda; O Nyč; E Klapková; V Barták; I Landor; D Pokorný; T Judl; A Sosna
Journal:  Folia Microbiol (Praha)       Date:  2012-05-16       Impact factor: 2.099

10.  Elastomeric high-mineral content hydrogel-hydroxyapatite composites for orthopedic applications.

Authors:  Jie Song; Jianwen Xu; Tera Filion; Eduardo Saiz; Antoni P Tomsia; Jane B Lian; Gary S Stein; David C Ayers; Carolyn R Bertozzi
Journal:  J Biomed Mater Res A       Date:  2009-06-15       Impact factor: 4.396

View more
  5 in total

1.  Bone Morphogenetic Protein-2 Promotes Human Mesenchymal Stem Cell Survival and Resultant Bone Formation When Entrapped in Photocrosslinked Alginate Hydrogels.

Authors:  Steve S Ho; Nina L Vollmer; Motasem I Refaat; Oju Jeon; Eben Alsberg; Mark A Lee; J Kent Leach
Journal:  Adv Healthc Mater       Date:  2016-09-01       Impact factor: 9.933

2.  Biodegradable PEG-Based Amphiphilic Block Copolymers for Tissue Engineering Applications.

Authors:  Artem B Kutikov; Jie Song
Journal:  ACS Biomater Sci Eng       Date:  2015-05-26

3.  A bioactive synthetic membrane improves bone healing in a preclinical nonunion model.

Authors:  Malcolm R DeBaun; Brett P Salazar; Yan Bai; Michael J Gardner; Yunzhi Peter Yang; Chi-Chun Pan; Alex Martin Stahl; Seydesina Moeinzadeh; Sungwoo Kim; Elaine Lui; Carolyn Kim; Sien Lin; L Henry Goodnough; Harsh Wadhwa
Journal:  Injury       Date:  2022-01-15       Impact factor: 2.586

Review 4.  Dual-functional composite scaffolds for inhibiting infection and promoting bone regeneration.

Authors:  Yutao Cui; He Liu; Yuhang Tian; Yi Fan; Shaorong Li; Gan Wang; Yanbing Wang; Chuangang Peng; Dankai Wu
Journal:  Mater Today Bio       Date:  2022-08-27

Review 5.  Biomaterials with Antibacterial and Osteoinductive Properties to Repair Infected Bone Defects.

Authors:  Haiping Lu; Yi Liu; Jing Guo; Huiling Wu; Jingxiao Wang; Gang Wu
Journal:  Int J Mol Sci       Date:  2016-03-03       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.